242 related articles for article (PubMed ID: 18172090)
1. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression.
Chen J; Guerriero E; Lathrop K; SundarRaj N
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):175-83. PubMed ID: 18172090
[TBL] [Abstract][Full Text] [Related]
2. Regulation of a Rho-associated kinase expression during the corneal epithelial cell cycle.
Anderson SC; SundarRaj N
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):933-40. PubMed ID: 11274069
[TBL] [Abstract][Full Text] [Related]
3. Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium.
Anderson SC; Stone C; Tkach L; SundarRaj N
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):978-86. PubMed ID: 11923237
[TBL] [Abstract][Full Text] [Related]
4. Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation.
Zhao Z; Rivkees SA
Dev Dyn; 2003 Jan; 226(1):24-32. PubMed ID: 12508221
[TBL] [Abstract][Full Text] [Related]
5. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ.
Joyce NC; Navon SE; Roy S; Zieske JD
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1566-75. PubMed ID: 8675399
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
[TBL] [Abstract][Full Text] [Related]
8. Synchronization of the G1/S transition in response to corneal debridement.
Chung EH; Hutcheon AE; Joyce NC; Zieske JD
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1952-8. PubMed ID: 10440248
[TBL] [Abstract][Full Text] [Related]
9. Role of the small GTP-binding protein rho in epithelial cell migration in the rabbit cornea.
Nakamura M; Nagano T; Chikama T; Nishida T
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):941-7. PubMed ID: 11274070
[TBL] [Abstract][Full Text] [Related]
10. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor.
Okumura N; Ueno M; Koizumi N; Sakamoto Y; Hirata K; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3680-7. PubMed ID: 19387080
[TBL] [Abstract][Full Text] [Related]
11. Rho-mediated regulation of TGF-beta1- and FGF-2-induced activation of corneal stromal keratocytes.
Chen J; Guerriero E; Sado Y; SundarRaj N
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3662-70. PubMed ID: 19324862
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
[TBL] [Abstract][Full Text] [Related]
13. A Rho-associated protein kinase: differentially distributed in limbal and corneal epithelia.
SundarRaj N; Kinchington PR; Wessel H; Goldblatt B; Hassell J; Vergnes JP; Anderson SC
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1266-72. PubMed ID: 9620089
[TBL] [Abstract][Full Text] [Related]
14. Accelerated growth of hepatocytes in association with Up-regulation of cyclin E in transgenic mice expressing the dominant negative form of retinoic acid receptor.
Tsutusmi A; Shiota G; Yamazaki H; Kunisada T; Terada T; Kawasaki H
Biochem Biophys Res Commun; 2000 Nov; 278(1):229-35. PubMed ID: 11071877
[TBL] [Abstract][Full Text] [Related]
15. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
16. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression.
Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; Buscà R; Ponzio G
Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
18. A negative modulatory role for rho and rho-associated kinase signaling in delamination of neural crest cells.
Groysman M; Shoval I; Kalcheim C
Neural Dev; 2008 Oct; 3():27. PubMed ID: 18945340
[TBL] [Abstract][Full Text] [Related]
19. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
[TBL] [Abstract][Full Text] [Related]
20. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
Glassford J; Rabin N; Lam EW; Yong KL
Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
